COM:MERSANA
Mersana Therapeutics
- Stock
Last Close
2.22
21/11 21:00
Market Cap
239.83M
Beta: -
Volume Today
1.01M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -2.09M - | -2.09M 0% | ||||||||
average payables | 2.05M - | 2.57M 25.53% | 6.90M 168.53% | 9.01M 30.63% | 7.82M 13.24% | 10.33M 32.14% | 13.14M 27.16% | 10.63M 19.04% | ||
average receivables | 845.50K - | 917.50K 8.52% | 621.50K 32.26% | 229.50K 63.07% | 15M - | 15M 0% | ||||
book value per share | -2.44 - | -3.18 30.28% | 5.82 283.11% | 0.38 93.44% | 1.80 371.58% | 3.71 106.01% | 1.72 53.50% | 0.98 43.01% | ||
capex per share | -0.04 - | -0.06 75.12% | -0.10 53.42% | -0.06 37.43% | -0.01 76.61% | -0.01 44.70% | -0.01 19.34% | -0.02 155.51% | ||
capex to depreciation | -2.08 - | -1.65 20.59% | -1.23 25.58% | -1.09 11.51% | -0.49 55.41% | -0.47 3.63% | -0.76 61.83% | -2.37 212.71% | 0.71 129.97% | |
capex to operating cash flow | 0.06 - | -0.03 153.42% | 0.03 178.04% | 0.02 7.35% | 0.01 64.01% | 0.01 29.09% | 0.00 26.90% | 0.04 861.49% | 0.01 71.16% | |
capex to revenue | -0.06 - | -0.04 27.93% | -0.07 51.27% | -0.13 98.50% | -0.01 88.89% | -0.57 3,877.36% | -15.07 2,538.01% | -0.08 99.45% | -0.06 28.83% | |
cash per share | 0.66 - | 5.73 769.58% | 9.54 66.44% | 3.04 68.09% | 2.29 24.65% | 4.15 80.82% | 2.52 39.23% | 4.62 83.19% | ||
days of inventory on hand | ||||||||||
days payables outstanding | ||||||||||
days sales outstanding | 22.55 - | 15.24 32.42% | 16.31 7.02% | 15.81 3.04% | 411.95 - | |||||
debt to assets | 0.07 - | 0.06 16.04% | 0.19 205.57% | 0.11 41.38% | 0.15 37.02% | |||||
debt to equity | 0.10 - | 0.07 26.71% | 0.31 331.60% | 0.39 25.75% | 0.91 131.10% | |||||
dividend yield | 0.00 - | 0.00 82.53% | 0.00 325.16% | |||||||
earnings yield | -0.07 - | -0.06 16.61% | -0.20 250.29% | -0.68 248.96% | -0.11 84.04% | -0.05 50.49% | -0.39 613.31% | -0.38 1.88% | ||
enterprise value | 233.37M - | 144.61M 38.04% | 170.94M 18.21% | 34.34M 79.91% | 194.62M 466.79% | 1.40B 618.11% | 299.24M 78.59% | 304.40M 1.72% | -140.93M 146.30% | |
enterprise value over ebitda | -14.55 - | -10.98 24.49% | -4.42 59.77% | -0.52 88.16% | -6.96 1,230.26% | -16.12 131.76% | -1.77 89.01% | -1.49 15.70% | 0.82 154.95% | |
ev to operating cash flow | -24.22 - | 4.58 118.90% | -4.01 187.49% | -0.62 84.47% | -2.87 361.97% | -18.71 551.27% | -2.14 88.58% | -6.17 188.48% | 0.83 113.53% | |
ev to sales | 22.53 - | 5.74 74.50% | 9.74 69.59% | 3.24 66.73% | 4.62 42.55% | 1.69K 36,432.37% | 6.96K 312.29% | 11.45 99.84% | -3.82 133.39% | |
free cash flow per share | -0.59 - | 1.74 397.45% | -3.64 309.03% | -2.46 32.60% | -1.57 36.03% | -1.22 22.21% | -1.99 62.98% | -0.55 72.37% | ||
free cash flow yield | -0.04 - | 0.12 397.45% | -0.22 278.11% | -0.60 171.43% | -0.27 54.45% | -0.05 83.25% | -0.32 597.26% | -0.09 70.67% | ||
graham net net | -2.58 - | -3.41 32.23% | 4.54 233.25% | -0.06 101.26% | 1.62 2,933.77% | 3.41 110.28% | 1.33 61.14% | 2.27 71.35% | ||
graham number | 7.18 - | 7.49 4.23% | 20.54 174.36% | 4.90 76.16% | 5.03 2.81% | 10.95 117.64% | 9.65 11.95% | 7.00 27.42% | ||
income quality | 0.59 - | -2.31 493.09% | 1.10 147.82% | 0.86 22.07% | 2.40 179.48% | 0.85 64.67% | 0.82 2.97% | 0.24 70.63% | 0.98 306.98% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -124.87 - | -244.25 95.61% | -133.95 45.16% | -61.51 54.08% | 42.15 168.53% | |||||
interest debt per share | 0.18 - | 0.28 49.74% | 0.56 102.94% | 0.42 24.28% | ||||||
inventory turnover | ||||||||||
invested capital | 0.10 - | 0.07 26.71% | 0.31 331.60% | 0.39 25.75% | 0.91 131.10% | |||||
market cap | 244.90M - | 244.90M 0% | 197.53M 19.34% | 93.97M 52.43% | 249.21M 165.20% | 1.64B 556.52% | 439.01M 73.17% | 548.81M 25.01% | ||
net current asset value | -44.35M - | -58.53M 31.99% | 56.82M 197.08% | 424K 99.25% | 72.10M 16,905.42% | 213.27M 195.78% | 104.53M 50.99% | 76.94M 26.40% | 24.90M 67.63% | |
net debt to ebitda | 0.72 - | 7.62 959.66% | 0.69 90.98% | 0.91 32.15% | 1.95 114.84% | 2.75 41.02% | 0.83 69.92% | 1.20 44.91% | 0.82 31.56% | |
net income per share | -0.94 - | -0.78 16.61% | -3.22 311.09% | -2.79 13.34% | -0.63 77.59% | -1.44 129.93% | -2.40 66.73% | -2.22 7.56% | ||
operating cash flow per share | -0.55 - | 1.81 427.81% | -3.55 296.59% | -2.40 32.47% | -1.56 35.03% | -1.21 22.01% | -1.98 63.26% | -0.53 73.43% | ||
payables turnover | ||||||||||
receivables turnover | 16.19 - | 23.95 47.97% | 22.38 6.56% | 23.08 3.14% | 0.89 - | |||||
research and ddevelopement to revenue | 2.06 - | 1.27 38.31% | 2.66 109.32% | 5.66 112.48% | 1.31 76.90% | 80.96 6,096.10% | 3.07K 3,692.02% | 6.52 99.79% | 4.02 38.32% | |
return on tangible assets | -1.14 - | -0.13 88.57% | -0.30 127.14% | -0.82 176.42% | -0.25 69.10% | -0.32 27.86% | -0.82 153.88% | -0.62 24.39% | -0.76 22.34% | |
revenue per share | 0.59 - | 1.44 142.99% | 1.46 1.42% | 0.46 68.48% | 0.97 110.56% | 0.01 98.61% | 0.00 95.48% | 0.28 46,486.80% | ||
roe | 0.38 - | 0.25 35.99% | -0.55 324.51% | -7.31 1,221.16% | -0.35 95.25% | -0.39 11.61% | -1.39 258.60% | -2.25 62.21% | -4.65 106.34% | |
roic | 0.38 - | 0.25 35.07% | -0.57 327.77% | -7.63 1,247.59% | -0.32 95.85% | -0.34 8.52% | -0.97 183.32% | -1.49 52.94% | -2.17 46.08% | |
sales general and administrative to revenue | 0.52 - | 0.28 46.25% | 0.60 114.91% | 1.54 158.57% | 0.41 73.39% | 26.45 6,346.94% | 857.86 3,143.12% | 2.14 99.75% | 1.62 24.61% | |
shareholders equity per share | -2.44 - | -3.18 30.28% | 5.82 283.11% | 0.38 93.44% | 1.80 371.58% | 3.71 106.01% | 1.72 53.50% | 0.98 43.01% | ||
stock based compensation to revenue | 0.03 - | 0.03 21.23% | 0.08 205.40% | 0.37 352.35% | 0.12 68.45% | 8.66 7,388.97% | 428.12 4,842.56% | 0.81 99.81% | 0.57 29.17% | |
tangible asset value | -42.69M - | -55.62M 30.28% | 69.99M 225.85% | 8.79M 87.43% | 78.32M 790.48% | 228.09M 191.23% | 121.74M 46.63% | 92.06M 24.38% | 36.90M 59.91% | |
tangible book value per share | -2.44 - | -3.18 30.28% | 5.82 283.11% | 0.38 93.44% | 1.80 371.58% | 3.71 106.01% | 1.72 53.50% | 0.98 43.01% | ||
working capital | 2.02M - | 73.79M 3,554.63% | 85.66M 16.09% | 706K 99.18% | 77.26M 10,842.78% | 228.58M 195.87% | 141.38M 38.15% | 227.69M 61.05% | 150.42M 33.94% |
All numbers in (except ratios and percentages)